NBC News
@NBCNews·11.9M subscribers·98K videos
Maker of popular diabetes and weight-loss drugs grilled about high cost in the U.S.
Posted
September 25, 2024
Views
2,642
Likes
27
Comments
14
Engagement
September 25, 2024
2,642
27
14
1.55%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
2:33Now PlayingThe CEO of Novo Nordisk was questioned about the high cost in the U.S. of Wegovy and Ozempic, the wildly popular diabetes and weight-loss drugs. Lars Jorgensen said pharmacy benefit managers are mostly to blame. NBC News' Stephanie Gosk reports.
» Subscribe to NBC News
» Watch more NBC video
NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.
Connect with NBC News Online!
NBC News App
Breaking News Alerts
Visit NBCNews.Com
Find NBC News on Facebook
Follow NBC News on Twitter
Follow NBC News on Instagram
#WeightLoss #Wegovy #Ozempic
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
